Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07781644 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

NCT07781644 · ClinicalTrials.gov record · last posted 2026-08-24

Study to Test Effects and Safety of RO7568282 in Early Parkinson's Disease

Name: Study to Test Effects and Safety of RO7568282 in Early Parkinson's Disease — clinical trial record (NCT07781644)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: TARBELA-PD

StatusNot Yet Recruiting

PhasePhase 1/2

SponsorHoffmann-La Roche

Started2026-09-30

View on ClinicalTrials.gov ↗

from the ClinicalTrials.gov record

The purpose of this study is to evaluate the efficacy, safety, and pharmacokinetics (PK) of RO7568282 compared with placebo in participants with early-stage Parkinson's disease (PD) on stable symptomatic monotherapy with levodopa.

Trial Details

NCT Number	NCT07781644
Lead Sponsor	Hoffmann-La Roche
Conditions	Parkinson's Disease
Enrollment	474 participants
Start Date	2026-09-30
Primary Completion	2028-12-15 (estimated)
Study Completion	2032-04-15 (estimated)
Updated on ClinicalTrials.gov	2026-08-24